Aurinia Pharmaceuticals Inc. Quarterly Assets in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Aurinia Pharmaceuticals Inc. quarterly Assets history and growth rate from Q4 2019 to Q3 2024.
Aurinia Pharmaceuticals Inc. Assets for the quarter ending September 30, 2024 was $549M, a 1.02% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$549M	-$5.65M	-1.02%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$524M	-$25.4M	-4.62%	Jun 30, 2024	10-Q	2024-08-01
Q1 2024	$517M	+$64.9M	+14.4%	Mar 31, 2024	10-Q	2024-05-02
Q4 2023	$548M	+$77.2M	+16.4%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$555M	+$66.7M	+13.7%	Sep 30, 2023	10-Q	2023-11-02
Q2 2023	$549M	+$66.8M	+13.8%	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$452M	-$55.1M	-10.9%	Mar 31, 2023	10-Q	2023-05-04
Q4 2022	$471M	-$72.5M	-13.3%	Dec 31, 2022	10-K	2024-02-15
Q3 2022	$488M	+$128M	+35.6%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$482M	+$95.9M	+24.8%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	$507M	+$89.8M	+21.5%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$543M	+$79.7M	+17.2%	Dec 31, 2021	10-K	2023-02-28
Q3 2021	$360M			Sep 30, 2021	10-Q	2021-11-03
Q2 2021	$386M			Jun 30, 2021	10-Q	2021-08-05
Q1 2021	$417M			Mar 31, 2021	10-Q	2021-05-06
Q4 2020	$464M	+$139M	+43%	Dec 31, 2020	10-K	2022-02-28
Q4 2019	$324M	+$178M	+122%	Dec 31, 2019	10-K	2021-02-24

* An asterisk sign (*) next to the value indicates that the value is likely invalid.